The Claim
Weekly administration of 6 mg sirolimus may affect systemic inflammation and biological aging markers, including high-sensitivity C-reactive protein (hs-CRP) and DNA methylation age, in older adults; however, these outcomes are exploratory, not validated as clinical endpoints, and require confirmation in larger studies.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 6 mg of sirolimus once a week might help reduce signs of aging and inflammation in older people, but we’re not sure yet and need bigger studies to confirm it.
See the scientific wording
Weekly 6 mg sirolimus dosing may influence systemic inflammation and biological aging markers such as hs-CRP and DNA methylation age in older adults, though these exploratory outcomes are not validated as clinical endpoints and require confirmation in larger studies.
What the research says
1 studyThe study gives older adults the same weekly sirolimus dose mentioned in the claim and checks if it affects inflammation and aging markers, just like the claim says—so it supports it, but more research is still needed.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.